| 1 |
33941661 | A Role for VCP/p97 in the Processing of Drug-Stabilized TOP2-DNA Covalent Complexes. | 2021 Jul |
1 |
| 2 |
31429692 | Molecular Docking Based Analysis to Elucidate the DNA Topoisomerase IIβ as the Potential Target for the Ganoderic Acid; A Natural Therapeutic Agent in Cancer Therapy. | 2020 |
1 |
| 3 |
31090963 | NEK5 interacts with topoisomerase IIβ and is involved in the DNA damage response induced by etoposide. | 2019 Oct |
2 |
| 4 |
31399497 | Intercalating TOP2 Poisons Attenuate Topoisomerase Action at Higher Concentrations. | 2019 Oct |
1 |
| 5 |
31449404 | Smoothed Potential MD Simulations for Dissociation Kinetics of Etoposide To Unravel Isoform Specificity in Targeting Human Topoisomerase II. | 2019 Sep 23 |
1 |
| 6 |
29447373 | Coupling the core of the anticancer drug etoposide to an oligonucleotide induces topoisomerase II-mediated cleavage at specific DNA sequences. | 2018 Mar 16 |
1 |
| 7 |
29765039 | STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion. | 2018 May 15 |
1 |
| 8 |
30297860 | Increasing the distance between two monomers of topoisomerase IIβ under the action of antitumor agent 4β-sulfur-(benzimidazole) 4'-demethylepipodophyllotoxin. | 2018 Oct 8 |
1 |
| 9 |
27974636 | Myeloperoxidase Enhances Etoposide and Mitoxantrone-Mediated DNA Damage: A Target for Myeloprotection in Cancer Chemotherapy. | 2017 Jan |
2 |
| 10 |
28110185 | Computational analysis of Amsacrine resistance in human topoisomerase II alpha mutants (R487K and E571K) using homology modeling, docking and all-atom molecular dynamics simulation in explicit solvent. | 2017 Mar |
1 |
| 11 |
27484510 | Synthesis and biological evaluation of C1-O-substituted-3-(3-butylamino-2-hydroxy-propoxy)-xanthen-9-one as topoisomerase IIα catalytic inhibitors. | 2016 Nov 10 |
1 |
| 12 |
25945730 | Differential Targeting of Human Topoisomerase II Isoforms with Small Molecules. | 2015 Jun 11 |
1 |
| 13 |
24327541 | The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1. | 2014 Feb |
7 |
| 14 |
24766193 | Etoposide quinone is a covalent poison of human topoisomerase IIβ. | 2014 May 20 |
1 |
| 15 |
24038465 | On the structural basis and design guidelines for type II topoisomerase-targeting anticancer drugs. | 2013 Dec |
1 |
| 16 |
22528119 | The polyphenolic ellagitannin vescalagin acts as a preferential catalytic inhibitor of the α isoform of human DNA topoisomerase II. | 2012 Jul |
1 |
| 17 |
22615413 | Model for MLL translocations in therapy-related leukemia involving topoisomerase IIβ-mediated DNA strand breaks and gene proximity. | 2012 Jun 5 |
1 |
| 18 |
22841979 | The structure of DNA-bound human topoisomerase II alpha: conformational mechanisms for coordinating inter-subunit interactions with DNA cleavage. | 2012 Dec 7 |
2 |
| 19 |
21778401 | Structural basis of type II topoisomerase inhibition by the anticancer drug etoposide. | 2011 Jul 22 |
1 |
| 20 |
20886683 | Chromatin remodelling at the topoisomerase II-beta promoter is associated with enhanced sensitivity to etoposide in human neuroblastoma cell lines. | 2010 Oct |
2 |
| 21 |
19230382 | Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase II alpha, DNA topoisomerase II beta, and nucleolin with BCR 2 of the ETO gene. | 2008 Nov-Dec |
1 |
| 22 |
16914690 | Topoisomerase IIB and an extracellular nuclease interact to digest sperm DNA in an apoptotic-like manner. | 2006 Nov |
1 |
| 23 |
15322234 | Mutation E522K in human DNA topoisomerase IIbeta confers resistance to methyl N-(4'-(9-acridinylamino)-phenyl)carbamate hydrochloride and methyl N-(4'-(9-acridinylamino)-3-methoxy-phenyl) methane sulfonamide but hypersensitivity to etoposide. | 2004 Sep |
1 |
| 24 |
9331091 | Role of topoisomerase II beta in the resistance of 9-OH-ellipticine-resistant Chinese hamster fibroblasts to topoisomerase II inhibitors. | 1997 Oct 1 |
1 |
| 25 |
9422071 | [Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide- and mAMSA-resistant cell lines]. | 1997 Dec |
1 |
| 26 |
7805045 | Relationship of DNA topoisomerase II alpha and beta expression to cytotoxicity of antineoplastic agents in human acute lymphoblastic leukemia cell lines. | 1995 Jan 1 |
1 |
| 27 |
8519659 | Relationship between expression of topoisomerase II isoforms and intrinsic sensitivity to topoisomerase II inhibitors in breast cancer cell lines. | 1995 Dec |
1 |